Records containing: Microscopic Polyangiitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-15Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine (Butantan-DV) in Patients With Autoimmune Rheumatic Diseases Living in Dengue-Endemic Areas
-
CLINICAL_TRIALS study record update · 2026-01-22Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
-
CLINICAL_TRIALS study record update · 2026-01-22VCRC Tissue Biorepository Collection Protocol
-
CLINICAL_TRIALS study record update · 2026-01-22VCRC Genetic Repository One-Time DNA Protocol
-
CLINICAL_TRIALS study record update · 2025-12-02Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator (BRAVO): a CanVasc Multicentre Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-25A Phase 1 Study Evaluating SC291, a Hypoimmune, Allogeneic CD19-directed CAR T Cell Therapy, in Subjects With Severe Relapsed or Refractory Autoimmune Diseases (GLEAM)
-
CLINICAL_TRIALS study record update · 2025-11-20MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis
-
CLINICAL_TRIALS study record update · 2025-09-05MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis II
-
CLINICAL_TRIALS study record update · 2024-10-15T-cell Infusion Targeting BCMA and CD19 for Refractory/Relapsed Systemic Lupus Erythematosus (SLE) Patients With or Without Organs Involvement
-
CLINICAL_TRIALS study record update · 2024-07-31A Randomized, Double-Blind, Active Comparator-Controlled Study to Evaluate the Effect of Obinutuzumab Versus Rituximab in PR3-Patients With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
-
CLINICAL_TRIALS study record update · 2024-07-19Hydroxychloroquine in ANCA Vasculitis Evaluation - A Multicentre, Randomised, Double-blind, Placebo-controlled Trial
-
CLINICAL_TRIALS study record update · 2024-06-04Establishment of an Enzyme-linked Immunosorbent Assay for the Recognition of Procalcitonin Variants and Characterization of Procalcitonin Variants in Patients With Hyperprocalcitonemia.
-
CLINICAL_TRIALS study record update · 2023-11-30Chronic Childhood Vasculitis: Characterizing the Individual Rare Diseases to Improve Patient Outcomes
-
CLINICAL_TRIALS study record update · 2023-03-14A Local Interventional Study in a Cohort of Patients With GPA, MPA and EGPA (PART 2 of "Vitamin D Status in ANCA-associated Vasculitis: Analysis of RDCRN-VCRC and Local Clinic Cohorts of Patients With GPA, MPA and EGPA")
-
CLINICAL_TRIALS study record update · 2022-07-12Determining Disease Activity Biomarkers in Individuals With Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
-
CLINICAL_TRIALS study record update · 2022-03-18An International, Open Label, Randomised Controlled Trial Comparing Rituximab With Azathioprine as Maintenance Therapy in Relapsing ANCA-associated Vasculitis
-
CLINICAL_TRIALS study record update · 2021-01-27Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
-
CLINICAL_TRIALS study record update · 2020-11-16Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis : a Predictive Factor of Clinical Outcome? (MONITUX)
-
CLINICAL_TRIALS study record update · 2019-10-16VCRC Validation of Patient-Reported Diagnostic Data
-
CLINICAL_TRIALS study record update · 2018-08-17Short-Course Glucocorticoids and Rituximab in ANCA-Associated Vasculitis
-
CLINICAL_TRIALS study record update · 2018-06-06The Journey of Patients With Vasculitis From First Symptom to Diagnosis
-
CLINICAL_TRIALS study record update · 2017-10-27Rituximab for Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (RAVE) Long-Term Follow-Up Study
-
CLINICAL_TRIALS study record update · 2016-08-19ACR/EULAR Endorsed Study to Develop New Diagnostic and Classification Criteria for Primary Systemic Vasculitis
-
CLINICAL_TRIALS study record update · 2016-08-17Prospective, Observational Safety Study of Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis Treated With Rituximab
-
CLINICAL_TRIALS study record update · 2016-01-28Impact of Vasculitis on Employment and Income. An Online Survey of Participants in the VCRC Patient Contact Registry